Skip to content

A first study in humans testing the safety and effects of KUP-101A in patients with certain advanced solid cancers

Status
Not yet recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2025-522402-21-00
Acronym
KUP-CT01
Enrollment
21
Registered
2025-11-12
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced solid tumors (cutaneous melanoma, cutaneous squamous cell carcinoma, Merkel cell carcinoma, mucosal melanoma, or basal cell carcinoma)

Interventions

None listed

Sponsors

Kupando GmbH
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

Germany

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026